Oncologic Therapies by Strauss, S J
Book Review
Oncologic Therapies
EE Volkes and HM Golomb (editors)
Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG. 2003. ISBN 3-540-43461-5 d77*
British Journal of Cancer (2004) 90, 1296. doi:10.1038/sj.bjc.6601671 www.bjcancer.com
& 2004 Cancer Research UK
             
The stated goal of the second edition of this text is to ‘provide a
brief introduction to the principles and practice of oncology’, the
book being aimed at junior doctors with an interest in oncology
and junior oncologists ‘seeking a brief and focused patient
management resource’. This is not an inconsiderable task and I
found these goals were met in a very accessible and readable
textbook
The book is divided into four parts with part one providing an
introduction to the major therapeutic modalities of cancer
management and the principles behind them. The chapters were
well presented and informative. I found the section on chemother-
apeutic agents and their mechanisms of action particularly helpful
and summarised in a useful manner, ending with a table that
provides for easy reference. Also included in this section was a
chapter on the development of new therapies, and some of the
ethical issues surrounding clinical trials, equipoise and the
complex issues involved in gaining informed consent for treat-
ment. As a substantial proportion of cancer therapy is based on
research protocols, this subject is relevant to many junior staff who
enter patients into clinical trials and seek informed consent. This
chapter is thus very useful for gaining a better understanding of
these issues that are critical to good clinical practice.
Part II is an introduction to the complications of malignancy
and its treatment, and provides a brief overview of supportive care.
This section was somewhat biased to a North American readership.
For example the National Comprehensive Cancer Network (NCCN)
guidelines were quoted for pain management, which are not used
in the United Kingdom. Nonetheless the information and
algorithms were helpful without being prescriptive. The chapter
on chemotherapy-induced emesis was well written and again the
use of comprehensive tables for the assessment of risk of emesis
will be a helpful guide to a junior doctor. I was also pleased to note
the inclusion of a chapter on quality of life, which is increasingly
recognised as an important aspect of patient management and
measure of treatment outcome. I was disappointed, however, at the
exclusion of any information on the late effects and complications
of therapy, as this too is important as the number of long-term
survivors increases.
Part III describes the management of specific haematological
malignancies and part IV describes solid tumours with chapters on
specific tumour sites. These chapters were well organised and the
standardised format was helpful as a resource, although the
amount of detail varied between chapters. For example, the chapter
on ovarian cancer was perhaps lacking in detail particularly in
relation to the treatment of recurrent disease. Unfortunately, there
was little or no use of pictorial or graphical representation and this
was particularly missed in the haematological chapters where
histopathological sections of peripheral blood, bone marrow or
tissue biopsies would have been useful. The information was
generally up to date and gave a good evidence-base for current
management strategies. I found the chapters with tables of current
data and trial results were more informative than those without.
There was no use of Kaplan–Meier survival curves, which may
have been a deliberate decision, however, their exclusion removed
an easily accessible representation of comparative and long-term
data. Overall, the reference lists were helpful and comprehensive
enough to enable further reading for those interested in specific
subjects. The indexing was however a little confusing and
incomplete at times.
One noticeable omission from the introductory part of the book
was a chapter about the genetic and molecular basis of cancer,
which already provides valuable insights into the pathogenesis of
many cancer types and also provides important prognostic
information. New technologies for investigation of malignancy
such as the use of gene expression profiling did certainly warrant a
description. In addition, a more general analysis of the future of
oncology and the basis for the development of new therapeutic
agents would have been interesting.
Despite these reservations, I found Dr Vokes and Dr Golomb’s
book readable and useful as a primary resource. I would
recommend this as a text for a dedicated junior oncologist, but
feel it is pricey for a clinician with an ‘interest in oncology’.
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